Back to RIGL
MACKENZIE FINANCIAL CORP → RIGL
MACKENZIE FINANCIAL CORP RIGL Position History
Rigel Pharmaceuticals, Inc.
Quarters held
5
Latest value
$863K
Q3 2026
Peak value
$1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $830K |
| Q4 2025 | $1M |
| Q1 2026 | $779K |
| Q2 2026 | $701K |
| Q3 2026 | $863K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $863K | 17.9K | — | — |
| Q2 2026 | $701K | 17.9K | — | — |
| Q1 2026 | $779K | 28.8K | — | — |
| Q4 2025 | $1M | 23.7K | — | — |
| Q3 2025 | $830K | 29.3K | — | — |
Other funds holding RIGL
$40.7M
$40.7M
$30.3M
$22.4M
$22.4M
$15.1M
$13.8M